28Jun
[Audio] Episode 148 -- A Review of the Novartis and Alcon FCPA Enforcement Action
Even during this difficult time of the pandemic, economic uncertainty and social unrest, the Justice Department and the SEC have concluded a major FCPA enforcement action. Novartis and Alcon (which was a Novartis subsidiary at the time of the misconduct) agreed to pay a total of $345 million in criminal and civil penalties. Novartis spun off Alcon in 2019. Under the DOJ settlement, Novartis and Alcon each entered into a deferred prosecution agreement; Novartis agreed to pay a fine of $225...
By:
Michael Volkov
Related
Employers in New Jersey and New York City need to review their drug testing policies and employment ...
Read More >
We recently wrote about a new California law set to go into effect on January 1, 2020 that would out...
Read More >
On September 24, 2019, the U.S. Department of Labor (DOL) announced a final rule, effective January ...
Read More >
As we look forward to 2020, we bring you a few key takeaways on the hot topics and trends that indiv...
Read More >
Part 2 in a PublicCEO Series - Previously, we discussed local governments’ response to the novel c...
Read More >
On December 13, 2019, the National Labor Relations Board (“Board”) issued a new Final Rule amendin...
Read More >